More tools:Markets·Screener·Research Chat

Cardinal Health, Inc. (CAH) Financial Statements

Cardinal Health, Inc.
SIC 5122 · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
FIGI BBG001S7PC34
XNYS · usd
230.11▼ 3.55 (-1.52%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$244.7B
Net Income (TTM)$1.7B
EBITDA
Diluted EPS (TTM)
EBITDA Margin1.4%
Net Debt
Trading Information
Previous Close233.66
Day's Range227.85 – 231.83
52-Week Range137.75 – 243.21
Volume3.12M
Avg Volume2.38M
Share Statistics
Shares Outstanding234.2M
Employees57.7K
ExchangeXNYS
Listed1983-08-04

Key questions about Cardinal Health, Inc. (CAH)

What is Cardinal Health, Inc.'s Market Cap?
Cardinal Health, Inc.'s Market Cap is $53.9B, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s Enterprise Value?
Cardinal Health, Inc.'s Enterprise Value is $59.4B, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s Trailing P/E?
Cardinal Health, Inc.'s Trailing P/E is 32.4×, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s Price / Sales?
Cardinal Health, Inc.'s Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s EV / Revenue?
Cardinal Health, Inc.'s EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s EV / EBITDA?
Cardinal Health, Inc.'s EV / EBITDA is 17.4×, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s Revenue (TTM)?
Cardinal Health, Inc.'s Revenue (TTM) is $244.7B, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s Net Income (TTM)?
Cardinal Health, Inc.'s Net Income (TTM) is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s EBITDA?
Cardinal Health, Inc.'s EBITDA is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is Cardinal Health, Inc.'s Diluted EPS (TTM)?
Cardinal Health, Inc.'s Diluted EPS (TTM) is 7.10, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Revenue
YoY growth+11.0%+18.8%+22.4%+0.8%
Cost of products sold
Gross margin
% of revenue4.1%3.7%3.6%3.7%
Operating expenses:
Distribution, selling, general and administrative expenses
Restructuring and employee severance
Amortization and other acquisition-related costs
Acquisition-related cash and share-based compensation costs
Impairments and (gain)/loss on disposal of assets, net
Litigation (recoveries)/charges, net—
Income (loss) from operations
% of revenue0.8%1.1%1.0%0.7%
Other (income)/expense, net
Interest expense, net———
Income (loss) before income taxes
Income tax expense (benefit)
Net earnings
% of revenue0.6%0.7%0.7%0.4%
Less: Net (earnings)/loss attributable to noncontrolling interests
Net earnings attributable to Cardinal Health, Inc.
% of revenue0.7%0.7%0.7%0.4%
Earnings per common share attributable to Cardinal Health, Inc.:
Basic————
Diluted————
Weighted-average number of common shares outstanding:
Basic
Diluted
Cash dividends declared per common share————